MEDITE GESELLSCHAFT FÜR MEDIZINTECHNIK MBH – Trademark Portfolio

Entity Type: 16

MEDITE GESELLSCHAFT FÜR MEDIZINTECHNIK MBH holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 1 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 3 Nice Classification classes. The owner is based in BURGDORF.

WOLLENWEBERSTRAßE 12

BURGDORF 31303 , DE

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

MEDITE
MEDITE
Cancelled 2007

Trademark Classifications

MEDITE GESELLSCHAFT FÜR MEDIZINTECHNIK MBH's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (1 filing)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does MEDITE GESELLSCHAFT FÜR MEDIZINTECHNIK MBH have?

MEDITE GESELLSCHAFT FÜR MEDIZINTECHNIK MBH has 1 U.S. trademark filed with the USPTO.

What trademark classes does MEDITE GESELLSCHAFT FÜR MEDIZINTECHNIK MBH file in?

MEDITE GESELLSCHAFT FÜR MEDIZINTECHNIK MBH files trademarks across 3 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 9 (Computers & Electronics), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What is MEDITE GESELLSCHAFT FÜR MEDIZINTECHNIK MBH's trademark registration success rate?

MEDITE GESELLSCHAFT FÜR MEDIZINTECHNIK MBH has a 0% trademark registration rate, with 0 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.